NCT03144063View on ClinicalTrials.gov

Improving the Assessment of SLE Disease Activity

CompletedOBSERVATIONAL

Enrollment

247

Participants

Timeline

Start Date

July 11, 2017

Primary Completion Date

June 4, 2020

Study Completion Date

June 4, 2020

Conditions

Lupus Erythematosus, SystemicSLE

Trial Locations (1)

M4L2P5

Toronto Western Hospital, Toronto

Sponsors

Collaborators (1)

GlaxoSmithKline

All Listed Sponsors

collaborator

GlaxoSmithKline

INDUSTRY

lead

University Health Network, Toronto

OTHER

NCT03144063 - Improving the Assessment of SLE Disease Activity | Biotech Hunter | Biotech Hunter